Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Experimental exophthalmos. Preliminary communication].

V P Stern, M Stern

    Arzneimittel-Forschung
    |April 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The XENONnT dark matter experiment.

    The European physical journal. C, Particles and fields·2024
    Same author

    Chronic PCSK9 inhibitor therapy leads to sustained improvements in endothelial function, arterial stiffness, and microvascular function.

    Microvascular research·2023
    Same author

    Microvascular tissue perfusion after postcatheterization pseudoaneurysm treatment.

    Clinical hemorheology and microcirculation·2022
    Same author

    Desynchronous learning in a physics-driven learning network.

    The Journal of chemical physics·2022
    Same author

    Sources for constellation errors in modulated dispersion interferometers.

    The Review of scientific instruments·2022
    Same author

    The Developmental Chronnecto-Genomics (Dev-CoG) study: A multimodal study on the developing brain.

    NeuroImage·2020
    Same journal

    Wirksamkeit und Verträglichkeit eines pflanzlichen Arzneimittels mit Kapuzinerkressenkraut und Meerrettich bei akuter Sinusitis, akuter Bronchitis und akuter Blasenentzündung im Vergleich zu anderen Therapien unter den Bedingungen der täglichen Praxis.

    Arzneimittel-Forschung·2013
    Same journal

    Abstracts of the Paul-Martini-Stiftung Symposium 2012 in combination with the National Academy of Leopoldina. November 16-17, 2012. Berlin, Germany.

    Arzneimittel-Forschung·2013
    Same journal

    Leave-one-out procedure in the validation of elimination rate constant analysis.

    Arzneimittel-Forschung·2012
    Same journal

    Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

    Arzneimittel-Forschung·2012
    Same journal

    Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

    Arzneimittel-Forschung·2012
    Same journal

    Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

    Arzneimittel-Forschung·2012
    See all related articles

    Catechol-O-methyl-transferase inhibitors, pyrogallol and RO-4-4602, induce exophthalmos in rodents. Local guanethidine application effectively suppresses this drug-induced exophthalmos.

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Ophthalmology

    Context:

    • Catechol-O-methyl-transferase (COMT) is a key enzyme in catecholamine metabolism.
    • COMT inhibitors, such as pyrogallol and RO-4-4602, are used in research and potentially therapeutics.
    • Exophthalmos, or bulging of the eyes, can be a side effect of certain pharmacological agents.

    Purpose:

    • To investigate the ocular effects of COMT inhibitors.
    • To determine if guanethidine can mitigate drug-induced exophthalmos.

    Summary:

    • Administration of pyrogallol and N1-(d,1-seryl)-N2-(2,3,4-trihydroxy-benzyl)-hydrazine (RO-4-4602), both COMT inhibitors, resulted in exophthalmos in mice and rats.
    • The observed exophthalmos was successfully reversed or suppressed by the local application of guanethidine.

    Related Experiment Videos

    Impact:

    • This study identifies a specific ocular side effect associated with COMT inhibition.
    • It suggests a potential therapeutic strategy for managing drug-induced exophthalmos using guanethidine.
    • Provides insights into the role of catecholamine pathways in ocular physiology and drug-induced toxicity.